Qiu, Ying; Fu, Alex; Liu, Gordon; Christensen, Dale - In: Applied Health Economics and Health Policy 8 (2010) 3, pp. 167-177
From a third-party payer perspective, atypical antipsychotic mono-therapy generated higher drug costs but lower medical care costs, resulting in equivalent total healthcare costs over a 1-year period. </AbstractSection> Copyright Adis Data Information BV 2010
